{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:57:40Z","timestamp":1782824260126,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.ejca.2009.07.022","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T06:23:10Z","timestamp":1251267790000},"page":"2659-2670","source":"Crossref","is-referenced-by-count":48,"title":["Process performance of cervical screening programmes in Europe"],"prefix":"10.1016","volume":"45","author":[{"given":"Guglielmo","family":"Ronco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein van","family":"Ballegooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Chil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Fender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Giubilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juozas","family":"Kurtinaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesz","family":"Lancucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsebeth","family":"Lynge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Sparen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia","family":"Suteu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matejka","family":"Rebolj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piret","family":"Veerus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja Primic","family":"\u017dakelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahti","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2009.07.022_bib1","series-title":"European guidelines for quality assurance on cervical cancer screening","article-title":"Epidemiological guidelines for quality assurance in cervical cancer screening","author":"Anttila","year":"2008"},{"key":"10.1016\/j.ejca.2009.07.022_bib2","unstructured":"Ronco G, vonKarsa L, Anttila A. Chapter 7. Key performance indicators. In: Arbyn M, Anttila A, Jordan J, et al., editors. European guidelines for quality assurance on cervical cancer screening. 2nd ed. Brussels: European Community; 2nd edition. Luxembourg: Office for Official Publications of the European Communities; 2008."},{"key":"10.1016\/j.ejca.2009.07.022_bib3","unstructured":"Cervical screening programme, England, 2006\u20137, NHS Information Centre, October 2007."},{"key":"10.1016\/j.ejca.2009.07.022_bib4","unstructured":"NHSCSP. Quality assurance guidelines for the cervical screening programme. NHSCSP Publication No. 3, January 1996."},{"key":"10.1016\/j.ejca.2009.07.022_bib5","unstructured":"<http:\/\/www.isdscotland.org\/isd\/1673.html>."},{"key":"10.1016\/j.ejca.2009.07.022_bib6","unstructured":"<http:\/\/www.screeningservices.org.uk\/csw\/prof\/reports\/index.asp>."},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2009.07.022_bib7","first-page":"37","article-title":"Extension of organised cervical cancer screening programmes in Italy and their process indicators","volume":"32","author":"Ronco","year":"2008","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.ejca.2009.07.022_bib8","unstructured":"Primic \u017dakelj M and the ZORA Group. Preliminary report on performance of the National Programme ZORA in the years 2002 and 2003. Ljubljana: Institute of Oncology Ljubljana; 2003. p. 1\u20138 [in Slovenian language]."},{"key":"10.1016\/j.ejca.2009.07.022_bib9","series-title":"Core indicators 2006 from PALEBA 2006\/PALGA (in Dutch)","author":"Rebolj","year":"2007"},{"key":"10.1016\/j.ejca.2009.07.022_bib10","unstructured":"Finnish Cancer Registry. Cancer in Finland 2004 and 2005. Cancer statistics of the National Research and Development Centre for Welfare and Health. Cancer Society of Finland Publication No. 72 ISSN 0585-9603. Helsinki, 2007 (88 pages)."},{"key":"10.1016\/j.ejca.2009.07.022_bib11","first-page":"834","article-title":"Pilot project of cervical cancer in Estonia","volume":"85","author":"Raud","year":"2006","journal-title":"Eesti Arst"},{"key":"10.1016\/j.ejca.2009.07.022_bib12","first-page":"1545","article-title":"EVE, une campagne r\u00e9gionale de d\u00e9pistage du cancer du col de l\u2019uterus","volume":"32","author":"Fender","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.ejca.2009.07.022_bib13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0959-8049(00)00308-7","article-title":"Cervical cancer screening in Belgium","volume":"36","author":"Arbyn","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib14","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0959-8049(00)00330-0","article-title":"Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness","volume":"36","author":"van Ballegooijen","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bjc.6602069","article-title":"Cervical cancer screening programmes and policies in 18 European countries","volume":"91","author":"Anttila","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib16","first-page":"77","article-title":"Zytologische Krebsvorsorge am Geb\u00e4rmutterhals: erste Ergebnisse einer 6-Jahres \u2013 analyse in Mecklenburg-Vorpommern","volume":"14","author":"B\u00fcttner","year":"2004","journal-title":"\u00c4rzteblatt Mecklenburg-Vorpommern"},{"key":"10.1016\/j.ejca.2009.07.022_bib17","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2009.07.022_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jcp.2003.011841","article-title":"The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996","volume":"57","author":"Bulk","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejca.2009.07.022_bib19","unstructured":"Bundes\u00e4rtzekammer. Qualit\u00e4tssicherungsvereinbarung Zervixzytologie. Deutsches \u00c4rzteblatt 104;36:A2446\u2013A2451 [in German]."},{"key":"10.1016\/j.ejca.2009.07.022_bib20","doi-asserted-by":"crossref","unstructured":"Working group on the registration and monitoring of cervical cancer screening programmes in the European Union. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009;45(15):2685\u2013708.","DOI":"10.1016\/j.ejca.2009.07.017"},{"issue":"15","key":"10.1016\/j.ejca.2009.07.022_bib21","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.ejca.2009.07.020","article-title":"Policies for cervical screening programmes in Europe","volume":"45","author":"Anttila","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib22","unstructured":"Arbyn M, Dillner J, Schenck U et al. Chapter 3. Methods for screening and diagnosis. Annex II: recommendations for cervical cytology terminology. In: Arbyn M, Anttila A, Jordan J, et al., editors. European guidelines for quality assurance on cervical cancer screening, 2nd ed. Luxembourg: Office for Official Publications of the European Communities; 2008."},{"key":"10.1016\/j.ejca.2009.07.022_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2303.1998.00220.x","article-title":"Observer variation in gynaecological cytopathology","volume":"9","author":"O\u2019 Sullivan","year":"1998","journal-title":"Cytopathology"},{"key":"10.1016\/j.ejca.2009.07.022_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1097-0142(19970825)81:4<212::AID-CNCR3>3.0.CO;2-R","article-title":"Use of statistical analysis of cytologic interpretation to determine the causes of interobserver disagreement and in quality improvement","volume":"81","author":"Renshaw","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib25","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2009.07.022_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cncr.10317","article-title":"Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia and the United Kingdom","volume":"96","author":"Scott","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2303.2003.00035.x","article-title":"Effect of circulation and discussion of cervical smears on agreement between laboratories","volume":"14","author":"Ronco","year":"2003","journal-title":"Cytopathology"},{"key":"10.1016\/j.ejca.2009.07.022_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2009.07.022_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid-based versus conventional cytology: overall results of the new technologies for cervical cancer screening randomised controlled trial","volume":"335","author":"Ronco","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2009.07.022_bib30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/bjc.1996.196","article-title":"Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer","volume":"73","author":"Sasieni","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib31","unstructured":"Zappa M, Ciatto S. Cervical cancer: case\u2013control studies on screening. In: Sankila R, Demaret E, Hakama M, Lynge E, Schouten LJ, Parkin DM, editors. Evaluation and monitoring of screening programmes. Europe against cancer programme. Brussels, Luxembourg, 2000. p. 99\u2013118."},{"key":"10.1016\/j.ejca.2009.07.022_bib32","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1159\/000332855","article-title":"Screening histories of incident cases of cervical cancer and high grade SIL. A comparison","volume":"41","author":"Baldauf","year":"1997","journal-title":"Acta Cytol"},{"key":"10.1016\/j.ejca.2009.07.022_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.bjc.6602705","article-title":"Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992\u201398","volume":"93","author":"Ronco","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib34","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/ijc.22114","article-title":"Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands","volume":"119","author":"Bos","year":"2006","journal-title":"Int J Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2009.07.022_bib35","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.ejca.2009.07.025","article-title":"Challenges in starting organised screening programmes for cervical cancer in the new member states","volume":"45","author":"Nicula","year":"2009","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2009.07.022_bib36","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV in Europe","volume":"45","author":"De Vuyst","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#","article-title":"International incidence rates of invasive cervical cancer before cytological screening","volume":"71","author":"Gustafsson","year":"1997","journal-title":"Int J Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2009.07.022_bib38","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.022_bib39","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/annonc\/mdm377","article-title":"Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004","volume":"18","author":"Arbyn","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2009.07.022_bib40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/bmj.298.6675.707","article-title":"Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia","volume":"298","author":"Ismail","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2009.07.022_bib41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1309\/K7C9-X5P0-001B-2HK5","article-title":"Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance","volume":"114","author":"Grenko","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejca.2009.07.022_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0029-7844(02)02058-6","article-title":"Discrepancy in the interpretation of cervical histology by gynaecologic pathologists","volume":"100","author":"Parker","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2009.07.022_bib43","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.ygyno.2005.07.040","article-title":"Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodology issues","volume":"99","author":"Malpica","year":"2005","journal-title":"Gynaecol Oncol"},{"issue":"15","key":"10.1016\/j.ejca.2009.07.022_bib44","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.ejca.2009.07.016","article-title":"The challenges of organising cervical screening programmes in the 15 old member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2009.07.022_bib45","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.ejca.2009.07.024","article-title":"What\u2019s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination","volume":"45","author":"Lynge","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909005759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909005759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T01:23:27Z","timestamp":1558488207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804909005759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":45,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0959804909005759"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2009.07.022","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}